Nvidia's Forward P/E Has Actually Fallen as Its Stock Price Rose. Here's How That's Possible.

Nvidia shares are up ~12% YTD, but its forward P/E has fallen to 23.2 (down from ~40 at end-July 2025), implying improving valuation driven by faster earnings growth than stock price. The article cites net income more than tripling YoY in fiscal 2027 Q1 and points to guidance of ~$91B revenue for fiscal 2027 Q2, implying >10% sequential sales growth that supports higher EPS forecasts and a lower forward multiple. Overall, it frames Nvidia as still outperforming the S&P 500 YTD and potentially able to rally further into its late-August earnings.

Analysis

The important mechanism here is not “valuation got cheaper,” it is that earnings power is still outrunning price, which keeps pulling in growth and quality-factor capital. That usually supports the stock over the next 1-3 months even without a big multiple re-rate, but it also raises the bar for any AI-linked name without visible earnings to justify its own premium. In other words, NVDA strength can be a drag on second-tier AI hardware and software names because allocators will prefer the one company with both scale and cash conversion.

The near-term catalyst is the late-August print: the market will care more about forward commentary on demand persistence than the headline quarter. If guidance confirms double-digit sequential growth, the whole semiconductor AI basket should tighten tighter around NVDA as the reference asset, with winners in foundry, networking, and high-bandwidth memory supply chains; if the guide softens, the unwind will be broad because NVDA is the capex sentiment bellwether.

Contrarianly, the consensus may be too comfortable treating a falling forward P/E as automatically bullish. That only holds if estimate revisions keep rising; if estimates are peaking, the multiple can look optically cheap right before a digestion phase. The main falsifier is any evidence that sequential revenue growth decelerates materially or margins stop expanding, which would compress not just NVDA but also the broader AI trade over 6-18 months.

Key Decisions for Investors

• No chase in cash equity today; use NVDA as a buy-on-weakness name only if it sells off 5-7% into earnings while still guiding to double-digit sequential revenue growth.
• For 1-3 month exposure, prefer long NVDA / short SOXX as a quality-vs-beta expression; the trade works if NVDA keeps compounding faster than the basket and fails if AI participation broadens materially beyond mega-cap leaders.
• If trading the earnings catalyst, structure NVDA call spreads into late-August rather than outright calls; the risk/reward is better if implied volatility is not already elevated, and it caps premium bleed if the print is merely “good, not great.”
• Watch AMD and the broader AI secondaries (SMH, AVGO, MRVL, ANET) for relative underperformance if NVDA re-accelerates; that would be the cleaner short leg than shorting the sector blindly.
• Set a falsifier alert: if management implies sequential growth slows to low single digits or gross margin guidance rolls over, reduce AI hardware exposure broadly; that would signal capex digestion rather than a transient pause.